Analysis of Therapeutic Oligonucleotides by UHPSEC-MALS
The oligonucleotide therapeutics field has seen remarkable progress over the last few years and oligonucleotides are increasingly recognized as potential therapeutic agents for a variety of diseases. Ultra-high performance size-exclusion chromatography can be used to analyze size heterogeneity of oligonucleotides
contributed by Tosoh |
A new application note describes the ability of size-exclusion chromatography to discriminate oligonucleotides differing by one base in length when using UHPLC or UHPLC-MALS. For this purpose, a new silica gel-based phase, TSKgel UPSW2000, with a pore size of 12.5 nm was applied, which is also perfectly suited for the analysis of smaller proteins and peptide aggregates.
Read the full article now
Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Analytical Scientist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.